2007 Extraordinary Professor for Public Health at the Medical Faculty of the Ruprecht-Karls-University in Heidelberg, Germany
2004 Habilitation (thesis topic: “Development of new strategies for malaria control in Africa“) at the Medical Faculty of the Ruprecht-Karls-University in Heidelberg, Germany.
1993 MPH (thesis topic: “The global impact of voluntary HIV counselling and testing services on the prevention of HIV and AIDS") at the Medical School, University of Hannover/Germany
1990 Dr. med. (thesis topic: “Prevalence and differential diagnosis of hepatomegaly in south-east Zaire”) at the Medical School, Free University of Berlin, Germany
1986 Medical Approbation, Medical School, Free University of Berlin, Germany

Projects & Grants

Olaf Müller has been the principal investigator and co-investigator on grants for large community-based studies from a number of science funders, such as the German Science Foundation, MRC The Gambia, the European Union, the Bill and Melinda Gates Foundation, and the World Health Organization. He has also received research funding from the German Academic Exchange Service, from the Deutsche Gesellschaft für Internationale Gesundheit and from industry.

Publications

Olaf Müller has published a number of books in the field of Global Health as well as numerous book chapters.

KEY PUBLICATIONS

• Lu G, Nagbanshi M, Goldau N, Mendes Jorge M, Meissner P, Jahn A, Mockenhaupt FP, Müller O. Efficacy and safety of methylene blue in the treatment of malaria: a systematic review. BMC Medicine 16: 59 (2018)
• Dureab F, Shibib K, Yé Y, Jahn A, Müller O. Cholera in Yemen. Lancet Global Health online publication, October 10 (2018)
• Mendes Jorge M, Ouermi L, Meissner P, Compaoré G, Coulibaly B, Nebie E, Krisam J, Klose C, Kieser M, Jahn A, Lu G, D`Alessandro U, Sie A, Mockenhaupt FP,
• Müller O. Safety and efficacy of artesunate-amodiaquine combined with either methylene blue or primaquine in children with falciparum malaria in Burkina Faso: a randomized controlled trial. PLoS One 14(10): e0222993
• Dureab F, Jahn A, Krisam J, Dureab A, Zain O, Al-Awlaqi S, Müller O. Risk Factors Associated with the Recent Cholera Outbreak in Yemen: A Case-Control Study. Epidemiology and Health 41: e2019015 (2019)
• Razum O, Sridhar D, Jahn A, Zaidi S, Ooms G, Müller O. Polio: From eradication to sustained control. BMJ Global Health e001633 (2019)
• Müller O, Lu G, Von Seidlein L. Review: Geographic spread of Artemisinin resistance. Journal of Travel Medicine 26:4 (2019)
• Müller O, Lu G, Jahn A, Razum O. Malaria eradication. The Lancet 395: e68 (2020)
• Lemma GW, Renosa MD, Lu G, Müller O. GW eradication. Challenges in the last mile of the global Guinea Worm Eradication Program: A systematic review. Tropical Medicine & International Health 25 (12): 1432-40 (2020)
• Lu G. Razum O, Jahn A, Zhang Y, Sutton B, Sridhar D, Ariosha K, von Seidlein L, Müller O. Health Policy: COVID-19 in Germany and China: mitigation versus elimination strategy. Global Health Action 14: 1 (2021)
• Anna-Katharina Heuschen, Guangyu Lu, Oliver Razum, Alhassan Abdul-Mumin, Osman Sankoh, Lorenz von Seidlein, Umberto D`Alessandro, Olaf Müller. Public health relevant consequences of the COVID-19 pandemic on malaria in sub-Saharan Africa: A scoping review. Malaria Journal 20: 339 (2021)
• Anna-Katharina Heuschen, Alhassan Abdul-Mumin, Martin Adokiya, Guangyu Lu, Albrecht Jahn, Oliver Razum, Volker Winkler, Olaf Müller. Impact of the COVID-19 pandemic on malaria cases in health facilities in northern Ghana: A retrospective analysis of routine surveillance data. Malaria Journal 21: 149 (2022)
• Lu G, Zhang D, Chen J, Chai L, Liu K, Chang Z, Zhang Y, Lu Y, Heuschen A, Müller O, Zhu G, Cao J. Predicting the risk of malaria re-introduction in countries certified malaria free: a systematic review. Malaria Journal 22, 175 (2023)*. doi.org/10.1186/s12936-023-04604-4